R. Gerber

发表

Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry).

B. Yan, A. Íñiguez, R. D. de Winter, 2020, The American journal of cardiology.

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

S. Thom, J. Kooner, J. Mayet, 2018, The Lancet.

Renal artery sympathetic denervation: observations from the UK experience

M. Caulfield, A. Baumbach, C. Di Mario, 2016, Clinical Research in Cardiology.

Dual Antiplatelet Therapy After Drug-Eluting Stents Should Not Be Continued for More Than 1 Year and Preferably Indefinitely

A. Colombo, R. Gerber, 2008, Circulation. Cardiovascular interventions.

Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI

A. Jeremias, P. Serruys, G. Niccoli, 2017, The New England journal of medicine.

Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.

A. Jeremias, P. Serruys, G. Niccoli, 2018, JACC. Cardiovascular interventions.

Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment

Manesh R. Patel, A. Jeremias, P. Serruys, 2019, Journal of the American College of Cardiology.

Delayed mortality from aortic dissection post transcatheter aortic valve implantation (TAVI): The tip of the iceberg

R. Gerber, G. Mikhail, M. Osborn, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy.

Manesh R. Patel, A. Jeremias, P. Serruys, 2019, JACC. Cardiovascular interventions.

Percutaneous Coronary Intervention: Management of Complications

R. Gerber, C. Mario, Athanasios Kosovitsas, 2018 .

Long-Term Follow-Up on a Large Cohort of “Full-Metal Jacket” Percutaneous Coronary Intervention Procedures

A. Colombo, A. Ielasi, R. Gerber, 2009, Circulation. Cardiovascular interventions.

Contemporary Evidence, Treatment Strategies, and Indications for Chronic Total Occlusion-Percutaneous Coronary Intervention

R. Gerber, N. Mannakkara, D. Weeraman, 2017, European Medical Journal.

Percutaneous Coronary Intervention for Bifurcation Lesions: A State-of-the-Art Review of Techniques and Dedicated Devices

B. Sidhu, R. Gerber, 2016, EMJ Interventional Cardiology.

1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration.

B. Yan, A. Íñiguez, R. D. de Winter, 2020, International journal of cardiology.

1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry

B. Yan, A. Íñiguez, R. D. de Winter, 2020, International journal of cardiology. Heart & vasculature.

Sex differences in 1‐year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration

B. Yan, A. Íñiguez, M. Beijk, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO study

J. Tobis, A. Colombo, A. Ielasi, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Double-Blind, Placebo-Controlled Evaluation of Biorest Liposomal Alendronate in Diabetic Patients Undergoing PCI: The BLADE-PCI Trial: The BLADE-PCI Trial.

G. Stone, R. de Silva, A. Assali, 2022, American heart journal.

Contemporary Use of Intracoronary Imaging in Percutaneous Coronary Intervention

R. Gerber, Matthew E. Li, K. Wa, 2018, EMJ Cardiology.

Justification for complete revascularisation at the time of primary angioplasty

R. Gerber, I. Malik, 2010, Heart.

Revascularisation or medical therapy in elderly patients with acute anginal syndromes (RINCAL) A Randomised Trial.

A. Davie, R. Gerber, A. Myat, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

An unusual complication of coronary angiography via the radial approach.

J. Davies, R. Gerber, R. Al‐Lamee, 2015, European heart journal.

8B.07: RESULTS FROM THE UK RENAL DENERVATION AFFILIATION- 246 CASES FROM 17 CENTRES

J. Davies, S. Redwood, P. Mark, 2015, Journal of hypertension.

Aortic valve regurgitation after heterotopic heart transplantation: percutaneous treatment with transcatheter aortic valve implantation.

R. Gerber, M. Mullen, M. Reinthaler, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Does IVUS guidance of coronary interventions affect outcome? a prime example of the failure of randomized clinical trials

A. Colombo, R. Gerber, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation

D. Stub, D. Liew, R. Gerber, 2021, Circulation. Cardiovascular quality and outcomes.

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

M. Uder, A. Cremer, P. Gosse, 2021, The Lancet.

844 Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis

D. Stub, D. Liew, R. Gerber, 2020 .

Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.

Giuseppe Biondi-Zoccai, Giuseppe Musumeci, Giulio Guagliumi, 2012, JACC. Cardiovascular interventions.

Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score.

A. Colombo, G. Sangiorgi, A. Ielasi, 2011, Cardiovascular revascularization medicine : including molecular interventions.

A SENIOR moment? Bare-metal stents in elderly patients

A. Gershlick, R. Gerber, 2018, The Lancet.

Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysis.

G. Stone, S. Ellis, D. Baim, 2010, JACC. Cardiovascular interventions.

Heparin-induced thrombocytopenia (HIT) as an unusual cause of acute stent thrombosis.

J. Kooner, R. Gerber, R. Al‐Lamee, 2010, European Heart Journal.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Neil Chapman, Manish Saxena, Jai Radhakrishnan, 2018, The Lancet.

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†

W. Desmet, J. Wykrzykowska, V. Ntziachristos, 2015, European heart journal.

Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials.

D. Kereiakes, R. Gerber, J. Elassal, 2018, Atherosclerosis.

A clinical enigma of ongoing constrictive pericarditis.

R. Gerber, J. Baksi, R. Amin, 2017, Clinical medicine.

Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease

F. Harrell, J. Mayet, J. Davies, 2019, Circulation.

Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease: Physiology-Stratified Analysis of ORBITA

F. Harrell, S. Thom, J. Mayet, 2018, Circulation.

Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?Response to Colombo and Gerber

A. Colombo, R. Gerber, 2008 .

Age is not a bar to PCI: Insights from the long‐term outcomes from off‐site PCI in a real‐world setting

Robert T Gerber, Satpal S Arri, Mohamed O Mohamed, 2017, Journal of interventional cardiology.

Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement

P. Serruys, J. Mayet, J. Davies, 2018, JACC. Cardiovascular interventions.

Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.

A. Jeremias, P. Serruys, G. Niccoli, 2019, JAMA cardiology.

Correct optimization of drug-eluting stents should be regarded in the same light as POETry.

A. Colombo, R. Gerber, 2008, The American journal of cardiology.

Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

D. Francis, R. Petraco, R. Gerber, 2021, Journal of the American Heart Association.

Clinical outcomes after unrestricted implantation of everolimus-eluting stents.

A. Colombo, G. Sangiorgi, A. Ielasi, 2009, JACC: Cardiovascular Interventions.

Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents.

R. Gerber, D. Hildick-Smith, Rupert P. Williams, 2014, International journal of cardiology.

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

M. Stoel, R. Oemrawsingh, D. Chan Pin Yin, 2023, Journal of clinical medicine.